Sanofi-Aventis Scans Asian Firms For Alliances In Biosimilar Development And Marketing
This article was originally published in PharmAsia News
Executive Summary
SINGAPORE - European drug maker Sanofi-Aventis is scouting for Asia-centric joint ventures or collaborative arrangements to accelerate its presence in the biosimilars space. Sanofi is hoping to make up ground as some of its global peers have advanced in the segment to capitalize on some of the biggest revenue drivers expected to unfold in the next five to eight years